MISONIX, Inc. (NASDAQ:MSON) headquartered in Farmingdale, will host a conference call for the investment community to discuss the 1Q21 financial results on 5th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.misonix.com
Earnings Expectation
MISONIX, Inc. is reporting first quarter earnings results on Thursday 5th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.3 per share from $ 17.34 million in revenue. For the full year, analysts predict revenues of $ 78.50 million, while looking forward to loss of $ 0.79 per share.
The Company Outlook
Revenue for 1Q21 are expected in a range of $ 17.70 million ~ $ 17.70 million
Click Here For More Historical Outlooks Of MISONIX, Inc.
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications.
